期刊文献+

丙泊酚联合咪达唑仑在先天性心脏病患儿术后的镇静研究 被引量:7

Sedative effect of propofol combined with midazolam for postoperative pediatric patients with congenital heart disease
原文传递
导出
摘要 目的观察丙泊酚联合咪达唑仑在先天性心脏病患儿术后镇痛镇静的临床疗效。方法 58名先天性心脏病患儿分为对照组29例和试验组29例。试验组予以咪达唑仑0.2μg·kg^(-1)·min^(-1),连续给药至拔管后1 h,丙泊酚10μg·kg^(-1)·min^(-1)连续给药至拔管后1 h;对照组术后使用咪达唑仑1μg·kg^(-1)·min^(-1),连续给药至拔管后1 h。比较2组患儿术后的拔管时间、在重症监护室(ICU)停留的时间以及苏醒后谵妄的发生率。结果试验组患儿的拔管时间为(30.31±3.52)h,显著低于对照组的(38.22±4.41)h(P<0.05)。试验组患儿在ICU的停留时间为(43.22±5.11)h,显著低于对照组的(51.52±5.83)h(P<0.05)。对照组5例(17.2%)患儿在苏醒后出现谵妄,试验组4例(13.8%),差异无统计学意义(P>0.05)。结论丙泊酚联合咪达唑仑可以减少先天性心脏病患儿术后的拔管时间和在ICU停留时间。 Objective To observe the clinical efficacy of propofol combined with midazolam for pediatric patients with congenital heart disease requiring postoperative sedation.Methods Fifty- eight patients with congenital heart disease were divided into control group(n = 29) and treatment group(n = 29).Patients in control group received midazolam 1μg·kg^-1·min^-1 consecutively until 1 hour post extubation,patients in treatment group received midazolam 0.2 μg·kg^-1·min^-1 consecutively plus propofol 10 μg·kg^-1·min^-1 consecutively until 1 hour post extubation.The extubation time,intensive care unit(ICU) stay time and delirium incidence were evaluated.Results The extubation time(38.22±4.41) h and ICU stay time(51.52±5.83) h in control group were longer than those in treatment group,which were(30.31±3.52),(43.22±5.11) h(P〈0.05).The incidence of delirium in control group was 5 cases(17.2%),and 4 cases in treatment group(13.8%,P〉0.05).Conclusion For pediatric patients with congenital heart disease requiring postoperative sedation,application of propofol combined with midazolam can lower the extubation time and ICU stay time.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2015年第24期2378-2380,共3页 The Chinese Journal of Clinical Pharmacology
基金 2013年省医药卫生平台骨干人才计划基金资助项目(2013RCB012)
关键词 丙泊酚 咪达唑仑 儿童 先天性心脏病 镇静 镇痛 propofol midazolam child congenital heart disease sedation analgesia
  • 相关文献

参考文献10

  • 1Goldmuntz E, Paluru P, Glessner J,et al. Microdeletions and mi- croduplications in patients with congenital heart disease and multiple congenital anomalies[ J]. Congenit Heart Di,, 2011,6:592 -602.
  • 2Mahle WT, Martin GR, Beckman RH 3rd,et al. Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease[ J]. Pediatrics, 2012, 129 : 190 - 192.
  • 3Williams GD, Jones TK, Hanson KA, et al. The hemodynamic effects of propofol in chiMren with congenital heart disease [ J ]. Anesth Analg, 1999, 89:1411 - 1416.
  • 4Stark 1Ll, Shekerdemian LS. Estimating intracardiac and extracardi- ac shunting in the setting of complex congenital heart disease [ J ]. Ann Pediatr Cardiol, 2013, 6:145 - 151.
  • 5Kunisawa T, Kurosawa A, Oikawa M,et al. A high dose of dexme- detomidine using the BIS monitorTM for diagnostic and interventional cardiac catheterization in a toddler with congenital heart disease [J]. JAnesth, 2012, 26:254-258.
  • 6Marino BS, Lipkin PH, Newburger JW, et al. Neurodevelopmental outcomes in children with congenital heart disease:evaluation and management a scientific statement from the American Heart Associa- tion [ J ]. Circulation, 2012, 126 : 1143 - 1172.
  • 7Tobias J D, Gupta P, Naguib A,et al. Dexmedetomidine:applica- tions for the pediatric patient with congenital heart disease [ J ]. Pediatr Cardiol, 2011, 32 : 1075 - 1087.
  • 8Bai J, Hsu L, Tang Y,et al. Validation of the COMFORT Behavior scale and the FLACC scale for pain assessment in Chinese children after cardiac surgery[ J]. Pain Manag Nurs, 2012, 13 : 18 - 26.
  • 9Rivenes SM, Lewin MB, Stayer SA,et al. Cardiovascular effects of sevoflurane, isotlurane, halothane, and fentanyl - midazolam in children with congenital heart disease : an echocardiograpbic study of myocardial contractility and hemodynamics [ J ]. Anesthesiology, 2001, 94:223 - 229.
  • 10Xia WF, Liu Y, Zhou Qs,et al. Comparison of the effects of propo- fol and midazolam on inflammation and oxidase stress in children with congenital heart disease undergoing cardiac surgery[ J]. Yonsei Med J, 2011, 52:326-332.

同被引文献66

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部